IL17A and chronic inflammatory demyelinating polyradiculoneuropathy: In addition, our study was specifically designed to identify prognostic markers of the IVIg treatment response in CIDP and we identify IL-17 as one potential prognostic factor in chronic inflammatory neuropathies.